Teleflex Incorporated (NYSE:TFX) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Teleflex has a consensus “Hold” rating from 12 analysts: six holds, four buys, one strong buy and one sell. The average 12-month price target is $152.90, above the reported share price of $132.19.
• Teleflex beat quarterly expectations, reporting $1.76 EPS versus the $1.28 consensus and revenue of $570.33 million, up 28.9% year over year. Analysts expect approximately $7.26 in EPS for the current fiscal year.
• The company declared a quarterly dividend of $0.34, equal to $1.36 annually and a 1.0% yield. Institutional investors and hedge funds own approximately 95.62% of outstanding shares.

Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) have been assigned a consensus rating of "Hold" from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, six have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $152.90.

Several research firms have issued reports on TFX. Truist Financial upped their price objective on shares of Teleflex from $143.00 to $150.00 and gave the company a "hold" rating in a research note on Monday, August 10th. Needham & Company LLC lifted their target price on Teleflex from $159.00 to $170.00 and gave the stock a "buy" rating in a research report on Tuesday, August 25th. BMO Capital Markets initiated coverage on Teleflex in a report on Wednesday, July 8th. They issued an "outperform" rating and a $159.00 target price for the company. Weiss Ratings reissued a "sell (d)" rating on shares of Teleflex in a research report on Wednesday, June 24th. Finally, Piper Sandler restated an "overweight" rating and set a $169.00 price target (up from $160.00) on shares of Teleflex in a research note on Friday, August 7th.

Teleflex Price Performance

Shares of NYSE TFX opened at $132.19 on Friday. The stock's 50-day simple moving average is $135.78 and its 200-day simple moving average is $127.98. The firm has a market capitalization of $5.60 billion, a PE ratio of -5.68, a price-to-earnings-growth ratio of 0.90 and a beta of 0.82. Teleflex has a fifty-two week low of $100.18 and a fifty-two week high of $145.00. The company has a debt-to-equity ratio of 0.94, a quick ratio of 2.12 and a current ratio of 2.60.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, August 6th. The medical technology company reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analysts' expectations of $559.59 million. Teleflex had a negative net margin of 39.67% and a positive return on equity of 11.93%. The company's revenue for the quarter was up 28.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.73 EPS. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities research analysts forecast that Teleflex will post 7.26 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Friday, August 14th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 14th. Teleflex's dividend payout ratio is presently -5.84%.

Hedge Funds Weigh In On Teleflex

A number of institutional investors have recently modified their holdings of TFX. Kelleher Financial Advisors acquired a new stake in Teleflex during the 2nd quarter worth $25,000. Banque Cantonale Vaudoise raised its holdings in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company's stock valued at $31,000 after buying an additional 113 shares during the last quarter. UMB Bank n.a. raised its holdings in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company's stock valued at $38,000 after buying an additional 113 shares during the last quarter. Allworth Financial LP acquired a new stake in shares of Teleflex during the second quarter worth about $44,000. Finally, Kestra Advisory Services LLC purchased a new position in shares of Teleflex during the fourth quarter worth about $45,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.